Achieving Clinical Remission for Patients With Rheumatoid Arthritis

被引：17
|
作者：
Aletaha, Daniel [1 ]
Smolen, Josef S. [1 ]
机构：
[1] Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2019年 / 321卷 / 05期
关键词：
LOW DISEASE-ACTIVITY; ULTRASOUND; PROGRESSION; TARGET; DAMAGE;
D O I：
10.1001/jama.2018.21249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：457 / 458
页数：2
相关论文
共 50 条
  • [31] Chemokines and matrix metalloproteinase expression in rheumatoid arthritis (RA) patients achieving remission.
    Katrib, A
    Smith, M
    Ahern, M
    Roberts-Thompson, P
    Bertouch, JV
    McNeil, HP
    Youssef, PP
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S78 - S78
  • [32] Changes in synovial membrane pathology in rheumatoid arthritis patients achieving an ACR remission.
    Smith, MD
    Kraan, M
    Papengelis, V
    Weedon, H
    Coleman, M
    Roberts-Thomson, PJ
    Ahern, MJ
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S242 - S242
  • [33] POTENTIAL PREDICTORS FOR ACHIEVING AND/OR MAINTAINING LOW DISEASE ACTIVITY OR REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Akkoc, N.
    Zerbini, C. A.
    Karateev, D.
    Pedersen, R.
    Vlahos, B.
    Marshall, L.
    Bao, C.
    Al-Maini, M.
    Shen, Q.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 201 - 202
  • [34] DISCORDANCE OF CLINICAL REMISSION AND IMAGING REMISSION BY ULTRASONOGRAPHY IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH BIOLOGIC AGENTS
    Kondo, Y.
    Kaneko, Y.
    Saito, S.
    Ohta, Y.
    Sakata, K.
    Inoue, Y.
    Takahashi, C.
    Hiramoto, K.
    Inamo, J.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 986 - 986
  • [35] The Clinical Characteristics of Rheumatoid Arthritis Patients in Clinical Remission: Many Faces of DAS-28 Remission
    Son, Kyeong Min
    Kim, Inje
    Kim, Hyun Ah
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S130 - S130
  • [36] ULTRASONOGRAPHY IS USEFUL FOR PREDICTING BOOLEAN REMISSION AFTER ACHIEVING DAS28-BASED CLINICAL REMISSION OF RHEUMATOID ARTHRITIS
    Yoshimi, R.
    Hama, M.
    Takase, K.
    Sugiyama, Y.
    Kishimoto, D.
    Watanabe, R.
    Uehara, T.
    Asami, Y.
    Ihata, A.
    Ueda, A.
    Takeno, M.
    Ishigatsubo, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 758 - 758
  • [37] ATTEMPTS TO WITHDRAW ETANERCEPT IN RHEUMATOID ARTHRITIS PATIENTS MAINTAINING CLINICAL REMISSION
    Kamiya, M.
    Kikuchi, H.
    Soen, S.
    Okada, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 940 - 940
  • [38] Discontinuation of etanercept in patients with rheumatoid arthritis who were in clinical remission
    Tomoya Miyamura
    Koshiro Sonomoto
    Masataka Nakamura
    Yoshiro Horai
    Soichiro Takahama
    Hitoshi Ando
    Rumi Minami
    Masahiro Yamamoto
    Eiichi Suematsu
    Clinical Rheumatology, 2010, 29 : 87 - 90
  • [39] ASSESSMENT OF POWER DOPPLER SYNOVITIS IN RHEUMATOID ARTHRITIS PATIENTS WITH CLINICAL REMISSION
    Fakhfakh, R.
    El Amri, N.
    Baccouche, K.
    Zeglaoui, H.
    Bouajina, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1390 - 1390
  • [40] Discontinuation of etanercept in patients with rheumatoid arthritis who were in clinical remission
    Miyamura, Tomoya
    Sonomoto, Koshiro
    Nakamura, Masataka
    Horai, Yoshiro
    Takahama, Soichiro
    Ando, Hitoshi
    Minami, Rumi
    Yamamoto, Masahiro
    Suematsu, Eiichi
    CLINICAL RHEUMATOLOGY, 2010, 29 (01) : 87 - 90
12345